Medication info
Amdikabq 30/2.5 mg Tablets

Amdikabq 30/2.5 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate›33.005mg / 1 tabletS-Amlodipine Besylate 2.5 Hydrate›3.74mg / 1 tablet
Manufacturer / importer
Youngpoong Pharmaceutical Co., Ltd.
Appearance
White, rounded square film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202300141 · Approved 2023.01.06 · Insurance code 661905770

Summary

Main use
Treatment of essential hypertension inadequately controlled with fimasartan monotherapy
Who takes it
Adults · Children
Adult dose
Adults The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using fimasartan; however, if blood pressure is not controlled as described below, a direct switch to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Elderly patients No initial dose adjustment is required in elderly patients 70 years of age or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with this medicine containing fimasartan 30 mg. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients 18 years of age or younger.

Ingredients

Manufacturer
Youngpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension inadequately controlled with fimasartan monotherapy

  • Essential hypertension
View approved original text

This medication helps to lower blood pressure more effectively in patients with essential hypertension who are not sufficiently controlled on monotherapy with pimodivir potassium. It is used to improve blood pressure control and reduce the risk of cardiovascular disease.

How to take

Adult dose

Adults The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using fimasartan; however, if blood pressure is not controlled as described below, a direct switch to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Elderly patients No initial dose adjustment is required in elderly patients 70 years of age or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with this medicine containing fimasartan 30 mg. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy of this medicine have not been established in pediatric and adolescent patients 18 years of age or younger.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the ingredients of this medication, certain kidney diseases, liver dysfunction, biliary obstruction, and certain genetic metabolic disorders should not take this medication. Patients with depleted blood volume or sodium, impaired kidney function, renal artery hypertension, etc. should be cautious, as hypotension or worsening of kidney function may occur when taking this medication. Side effects such as dizziness, headache, edema, urinary disorders, insomnia, and flushing may occur, and in rare cases, severe kidney problems or allergic reactions may also occur. Due to the potential risk of hypotension, blood pressure and electrolyte status should be regularly monitored, particularly in patients on high-dose diuretics who need to be aware of symptoms of low blood pressure. This medication may interact with other antihypertensives, potassium-sparing diuretics, lithium preparations, and non-steroidal anti-inflammatory drugs, so it is critical to inform your healthcare provider of any other medications being taken. Pregnant or breastfeeding women are advised to avoid this medication, and careful consideration should be given in consultation with a healthcare professional if needed. Safety and efficacy in patients under 18 years of age have not been established, so its use is not recommended. Elderly patients may be more sensitive to this medication, so caution is advised when taking it. Patients with moderate to severe liver dysfunction should not take this medication. In case of overdose, severe hypotension and cardiac issues may occur; immediate medical attention should be sought, and emergency treatment may be necessary. This medication should be stored out of reach of children, and transferring it to another container can lead to quality degradation or accidents, which should be avoided.

Side effects

  • Dizziness
  • orthostatic dizziness
  • headache
  • facial swelling
  • peripheral edema
  • urinary disorders
  • insomnia
  • flushing
  • syncope
  • sedation
Show 194 more
  • migraine
  • indigestion
  • vomiting
  • nausea
  • upper abdominal pain
  • weakness
  • foreign body sensation
  • elevated liver enzyme levels
  • decreased platelet count
  • increased serum creatine phosphokinase
  • cough
  • muscle contraction
  • musculoskeletal stiffness
  • itching
  • localized urticaria
  • facial flushing
  • erectile dysfunction
  • fatigue
  • edema
  • palpitations
  • drowsiness
  • abdominal pain
  • nausea
  • weakness
  • lethargy
  • pain
  • weight gain
  • weight loss
  • hypotension
  • vasculitis
  • tension increase
  • sensory reduction
  • sensory disturbances
  • peripheral neuropathy
  • dysgeusia
  • tremors
  • extrapyramidal disorder
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • gastritis
  • gingival hypertrophy
  • pancreatitis
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • cough
  • dyspnea
  • rhinitis
  • hair loss
  • hyperhidrosis
  • purpura
  • skin discoloration
  • urticaria
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzyme levels
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • chest pain
  • hypotension
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • epigastric pain
  • diarrhea
  • loose stools
  • constipation
  • skin hyperemia
  • maculopapular rash
  • heaviness
  • warmth
  • impaired glucose tolerance
  • weakness
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuropathy
  • neuronitis
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal canal stenosis
  • acute pancreatitis
  • bowel obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • worsening of cerebral infarction
  • intracerebral hemorrhage
  • liver cancer
  • colon neoplasm
  • neoplasm of unknown origin
  • cervical cancer
  • prostate cancer
  • acute renal failure
  • chronic renal failure
  • nephrolithiasis
  • pyelonephritis
  • urinary incontinence
  • rhinitis
  • fibrosing alveolitis
  • pharyngitis
  • pneumonia
  • pulmonary disease
  • death
  • exacerbation of low back pain
  • osteoarthritis
  • arthrosis
  • hypoglycemia
  • hyperkalemia
  • pulmonary embolism
  • purpura
  • bradycardia
  • atrial fibrillation
  • coronary artery disease
  • aortic stenosis
  • heart failure
  • hypertension
  • acute hepatitis
  • benign pituitary neoplasm
  • otitis media
  • uterine prolapse
  • recurrent cancer
  • chest pain
  • low back pain
  • limb pain
  • neck/shoulder pain
  • fractures
  • muscle weakness
  • tendinitis
  • osteomyelitis
  • shoulder impingement syndrome
  • lateral epicondylitis
  • synovitis
  • sciatica
  • jaw pain
  • arthralgia
  • osteoporosis
  • myalgia
  • pharyngitis
  • upper respiratory infection
  • sputum
  • rhinitis
  • epistaxis
  • bronchitis
  • sensory disturbances
  • numbness
  • tremor
  • hypertonia
  • insomnia
  • depression
  • anxiety
  • memory impairment
  • appetite loss
  • gastroesophageal reflux
  • gastritis
  • diarrhea
  • constipation
  • functional gastrointestinal disorders
  • gastroenteritis
  • increased urination
  • urinary incontinence
  • nephrolithiasis
  • chronic renal failure
  • dysuria
  • hyperlipidemia
  • dyslipidemia
  • hypoglycemia
  • cerebral infarction
  • herpes zoster
  • visual disturbances
  • tachycardia
  • hypertension
  • purpura
  • fatty liver
  • localized inflammation
  • soft tissue infection
  • lymphadenopathy
  • postoperative pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that does not allow light to pass through. Additionally, it is important to maintain a temperature between 1 and 30 degrees Celsius when storing the medication to preserve its effectiveness.

Appearance and packaging

Appearance

White, rounded square film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.